We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+16.31%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$26.7M
Cap. Flow
+$13.4M
Cap. Flow %
9.95%
Top 10 Hldgs %
35.95%
Holding
101
New
21
Increased
28
Reduced
9
Closed
20

Top Buys

Rank Stock Value
1
FOLD
Amicus Therapeutics
FOLD
+$5.57M
2
ALCO icon
Alico
ALCO
+$2.28M
3
ELTX icon
Elicio Therapeutics
ELTX
+$1.81M
4
EXEL icon
Exelixis
EXEL
+$1.81M
5
MRK icon
Merck
MRK
+$1.47M

Top Sells

Rank Stock Value
1
ATER icon
Aterian
ATER
+$7.86M
2
AVNW icon
Aviat Networks
AVNW
+$3.95M
3
CLPT icon
ClearPoint Neuro
CLPT
+$3.34M
4
INTC icon
Intel
INTC
+$2.49M
5
GILD icon
Gilead Sciences
GILD
+$1.75M

Sector Composition

Rank Sector Weight
1 Healthcare 40.52%
2 Financials 13.92%
3 Technology 12.69%
4 Energy 10.02%
5 Materials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
1
Cytokinetics
CYTK
$10B
$7.56M 5.62%
325,000
– –
DRRX
2
DELISTED
DURECT Corp
DRRX
$5.27M 3.92%
265,000
– –
CLDR
3
DELISTED
Cloudera, Inc.
CLDR
$5.17M 3.84%
425,000
+25,000
+6% +$373K
ALCO icon
4
Alico
ALCO
$300M
$4.93M 3.66%
165,000
+75,000
+83% +$2.28M
TGB
5
Trekor Metals
TGB
$3.36B
$4.56M 3.39%
2,650,000
– –
FOLD
6
DELISTED
Amicus Therapeutics
FOLD
$4.45M 3.3%
450,000
+360,000
+400% +$5.57M
RNWK
7
DELISTED
RealNetworks Inc
RNWK
$4.36M 3.24%
1,025,000
-325,000
-24% -$1.13M
NMRK icon
8
Newmark Group
NMRK
$2.87B
$4.25M 3.16%
425,000
+25,000
+6% +$224K
INTT icon
9
inTEST
INTT
$142M
$4.07M 3.03%
345,000
-55,200
-14% -$472K
SFE
10
DELISTED
Safeguard Scientifics, Inc.
SFE
$3.75M 2.79%
550,000
+50,000
+10% +$363K
IMGN
11
DELISTED
Immunogen Inc
IMGN
$3.04M 2.26%
375,000
– –
TALO icon
12
Talos Energy
TALO
$2.78B
$2.71M 2.01%
225,000
– –
RBCAA icon
13
Republic Bancorp
RBCAA
$1.86B
$2.44M 1.81%
55,000
+10,795
+24% +$447K
BGC icon
14
BGC Group
BGC
$5.76B
$2.42M 1.79%
500,000
+25,000
+5% +$106K
ARKR icon
15
Ark Restaurants
ARKR
$19.8M
$2.32M 1.72%
115,000
– –
RLGT icon
16
Radiant Logistics
RLGT
$408M
$1.91M 1.42%
275,000
– –
CADE
17
DELISTED
Cadence Bancorporation
CADE
$1.87M 1.39%
90,000
– –
MRK icon
18
Merck
MRK
$366B
$1.85M 1.37%
25,152
+19,912
+380% +$1.47M
PFE icon
19
Pfizer
PFE
$159B
$1.81M 1.35%
50,000
+40,000
+400% +$1.42M
RNAC icon
20
Cartesian Therapeutics
RNAC
$290M
$1.81M 1.35%
13,333
+2,500
+23% +$310K
EXEL icon
21
Exelixis
EXEL
$13.5B
$1.81M 1.34%
+80,000
New +$1.81M
OSPN icon
22
OneSpan
OSPN
$610M
$1.72M 1.27%
70,000
+40,000
+133% +$981K
RIGL icon
23
Rigel Pharmaceuticals
RIGL
$868M
$1.71M 1.27%
50,000
+10,000
+25% +$396K
ELTX icon
24
Elicio Therapeutics
ELTX
$74.6M
$1.69M 1.26%
+9,375
New +$1.81M
VTRS icon
25
Viatris
VTRS
$18.8B
$1.68M 1.25%
120,000
+88,139
+277% +$1.44M
1
2 3 4 5

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $158M AUM 33.7% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

CM Management's Q1 2021 Portfolio in Review

As of Q1 2021, CM Management held 101 positions worth $135M, up 25% from $108M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

CM Management deployed $13.4M of net new capital in Q1 2021, opening 21 new positions and adding to 28 existing holdings. Its largest new stake was Elicio Therapeutics: 9,375 shares worth $1.69M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Aterian, an estimated $7.86M trimmed.

  • CM Management's largest Q1 2021 buy was Elicio Therapeutics: 9,375 shares worth $1.69M.
  • CM Management added most to Amicus Therapeutics in Q1 2021, an estimated $5.57M increase.
  • CM Management's biggest Q1 2021 reduction was Aterian, cutting an estimated $7.86M.
  • CM Management fully exited Aviat Networks in Q1 2021, selling an estimated $3.95M.
  • CM Management's ten largest holdings make up 36% of its $135M portfolio in Q1 2021.
  • CM Management opened 21 new positions and closed 20 in Q1 2021.
  • CM Management's portfolio value rose 25% quarter-over-quarter to $135M.

Based on CM Management's 13F filing for Q1 2021, filed 12 May 2021.